[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Vaccines Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

4          Type Overview

4.1       Introduction

4.1.1   Market Size & Forecast

4.2       Monovalent Vaccines

4.3       Multivalent Vaccines

5          Technology Overview

5.1       Introduction

5.1.1   Market Size & Forecast

5.2       Conjugate Vaccines

5.3       Inactivated and Subunit Vaccines

5.4       Live Attenuated Vaccines

5.5       Recombinant Vaccines

5.6       Toxoid Vaccines

6          Route of Administration Overview

6.1       Introduction

6.1.1   Market Size & Forecast

6.2       Intramuscular and Subcutaneous Administration

6.3       Oral Administration

6.4       Other Routes of Administration

7          Disease Indication

7.1       Introduction

7.1.1   Market Size & Forecast

7.2       Pneumococcal Disease

7.3       DTP

7.4       Influenza

7.5       HPV

7.6       Meningococcal Disease

7.7       Polio

7.8       Rotavirus

7.9       Hepatitis

7.10    MMR

7.11    Varicella

7.12    Dengue

7.13    Herpes Zoster

7.14    Others

8          Distribution Channel Overview

8.1       Introduction

8.1.1   Market Size & Forecast

8.2       Hospital Pharmacies

8.3       Retail Pharmacies

9          Regional Overview

9.1      Introduction

9.1.1   Market Size & Forecast

9.2      America

9.2.1   North America

9.2.1.1 U.S.

9.2.1.1.1         By Type

9.2.1.1.2         By Technology

9.2.1.1.3         By Route of Administration

9.2.1.2 Canada

9.2.1.2.1         By Type

9.2.1.2.2         By Technology

9.2.1.2.3         By Route of Administration

9.2.1.3 Mexico

9.2.1.3.1         By Type

9.2.1.3.2         By Technology

9.2.1.3.3         By Route of Administration

9.2.2   South America

9.2.2.1            By Type

9.2.2.2            By Technology

9.2.2.3            By Route of Administration

9.3      Europe           

9.3.1   Market Size & Forecast (Value)      

9.3.2   Western Europe

9.3.2.1 Germany      

9.3.2.1.1         By Type          

9.3.2.1.2         By Technology          

9.3.2.1.3         By Route of Administration            

           

9.3.2.2 France           

9.3.2.2.1         By Type          

9.3.2.2.2         By Technology

9.3.2.2.3         By Route of Administration

9.3.2.3 U.K.   

9.3.2.3.1         By Type          

9.3.2.3.2         By Technology

9.3.2.3.3         By Route of Administration

9.3.2.4 Italy   

9.3.2.4.1         By Type          

9.3.2.4.2         By Technology

9.3.2.4.3         By Route of Administration

9.3.2.5 Spain 

9.3.2.5.1         By Type          

9.3.2.5.2         By Technology

9.3.2.5.3         By Route of Administration

9.3.2.6 Rest of Western Europe     

9.3.2.6.1         By Type

9.3.2.6.2         By Technology

9.3.2.6.3         By Route of Administration

9.3.3   Eastern Europe

9.4      Asia Pacific    

9.4.1   Market Size & Forecast (Value)      

9.4.2   China 

9.4.2.1     By Type

9.4.2.2     By Technology

9.4.2.3     By Route of Administration

9.4.3   India

9.4.3.1     By Type

9.4.3.2     By Technology

9.4.3.3     By Route of Administration

9.4.4   Japan 

9.4.4.1     By Type     

9.4.4.2     By Technology

9.4.4.3     By Route of Administration       

9.4.5   South Korea  

9.4.5.1     By Type     

9.4.5.2     By Technology

9.4.5.3     By Route of Administration

9.4.6   Australia        

9.4.6.1     By Type     

9.4.6.2     By Technology

9.4.6.3     By Route of Administration

9.4.7   Rest of Asia-Pacific   

9.4.7.1     By Type     

9.4.7.2     By Technology

9.4.7.3     By Route of Administration       

9.5      Middle East & Africa

9.5.1   Market Size & Forecast (Value)      

9.5.2   The Middle East

9.5.2.1     South Africa

9.5.2.1.1         By Type          

9.5.2.1.2         By Technology

9.5.2.1.3         By Route of Administration

9.5.2.2     UAE

9.5.2.2.1         By Type          

9.5.2.2.2         By Technology

9.5.2.2.3         By Route of Administration

9.5.2.3     Qatar

9.5.2.3.1         By Type          

9.5.2.3.2         By Technology

9.5.2.3.3         By Route of Administration

9.5.2.4     Rest of Middle East

9.5.2.4.1         By Type

9.5.2.4 2         By Technology

9.5.2.4 3         By Route of Administration

9.5.3   Africa

9.5.3.1     By Type     

9.5.3.2     By Technology

9.5.3.3     By Route of Administration

10.      Company Profile                 

10.1    Pfizer Inc.

10.1.1 Company Overview 

10.1.2 Financial Performance         

10.1.3 Recent Developments         

10.1.4 Product Portfolio     

10.2    GlaxoSmithKline plc

10.2.1 Company Overview 

10.2.2 Financial Performance         

10.2.3 Recent Developments         

10.2.4 Product Portfolio     

10.3    Merck & Co., Inc.

10.3.1 Company Overview 

10.3.2 Financial Performance         

10.3.3 Recent Developments         

10.3.4 Product Portfolio     

10.4    Sanofi Pasteur Limited

10.4.1 Company Overview 

10.4.2 Financial Performance         

10.4.3 Recent Developments         

10.4.4 Product Portfolio     

10.5    CSL Limited

10.5.1 Company Overview 

10.5.2 Financial Performance         

10.5.3 Recent Developments         

10.5.4 Product Portfolio     

10.6    Emergent BioSolutions Inc.

10.6.1 Company Overview 

10.6.2 Financial Performance         

10.6.3 Recent Developments         

10.6.4 Product Portfolio     

10.7    Johnson & Johnson Services

10.7.1 Company Overview 

10.7.2 Financial Performance         

10.7.3 Recent Developments         

10.7.4 Product Portfolio     

10.8    AstraZeneca

10.8.1 Company Overview 

10.8.2 Financial Performance         

10.8.3 Recent Developments         

10.8.4 Product Portfolio     

10.9    AstraZeneca

10.9.1 Company Overview 

10.9.2 Financial Performance         

10.9.3 Recent Developments         

10.9.4 Product Portfolio

10.10  Astellas Pharma Inc.

10.10.1 Company Overview

10.10.2 Financial Performance       

10.10.3 Recent Developments       

10.10.4 Product Portfolio

10.11  Serum Institute of India Pvt. Ltd.

10.11.1 Company Overview           

10.11.2 Financial Performance       

10.11.3 Recent Developments       

10.11.4 Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports